146 related articles for article (PubMed ID: 760456)
1. The pill and circulatory disease.
Beral V; Kay C
Am Heart J; 1979 Feb; 97(2):263-4. PubMed ID: 760456
[No Abstract] [Full Text] [Related]
2. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.
Inman WH; Vessey MP
Br Med J; 1968 Apr; 2(5599):193-9. PubMed ID: 5653024
[No Abstract] [Full Text] [Related]
3. Thrombo-embolism and the pill.
Med J Aust; 1969 Jul; 2(2):67-8. PubMed ID: 5803860
[No Abstract] [Full Text] [Related]
4. Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee.
Br Med J; 1967 May; 2(5548):355-9. PubMed ID: 6023133
[No Abstract] [Full Text] [Related]
5. Oral contraceptives and mortality trends from thromboembolism in the United States.
Markush RE; Seigel DG
Am J Public Health Nations Health; 1969 Mar; 59(3):418-34. PubMed ID: 5813159
[No Abstract] [Full Text] [Related]
6. An analysis of the reported association of oral contraceptives to thromboembolic disease.
Odell WD
West J Med; 1975 Jan; 122(1):26-33. PubMed ID: 1089003
[No Abstract] [Full Text] [Related]
7. Oral contraception. A review of reported physiological and pathological effects.
Andrews WC
Obstet Gynecol Surv; 1971 Jul; 26(7):477-99. PubMed ID: 4950894
[No Abstract] [Full Text] [Related]
8. [Peroral contraceptives and thromboembolism].
Asperger Z
Lijec Vjesn; 1969 Jul; 91(7):779-82. PubMed ID: 4910828
[No Abstract] [Full Text] [Related]
9. [Hormonal contraception and blood coagulation disorders].
Schander K; Plotz EJ
Med Klin; 1974 Feb; 69(7):265-71. PubMed ID: 4596111
[TBL] [Abstract][Full Text] [Related]
10. [The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature].
Herzog C; Mall-Haefeli M
Ther Ggw; 1979 Oct; 118(10):1550-74. PubMed ID: 386549
[No Abstract] [Full Text] [Related]
11. [Thromboembolism during oral contraception. A critical review of the literature].
Dalgaard JB; Gregersen M
Nord Med; 1968 Nov; 80(45):1509-15. PubMed ID: 4884843
[No Abstract] [Full Text] [Related]
12. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report.
Vessey MP; Doll R
Br Med J; 1969 Jun; 2(5658):651-7. PubMed ID: 5783122
[TBL] [Abstract][Full Text] [Related]
13. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs.
Inman WH; Vessey MP; Westerholm B; Engelund A
Br Med J; 1970 Apr; 2(5703):203-9. PubMed ID: 5443406
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolism and oral contraceptives: an epidemiologic case-control study.
Sartwell PE; Masi AT; Arthes FG; Greene GR; Smith HE
Am J Epidemiol; 1969 Nov; 90(5):365-80. PubMed ID: 5395236
[No Abstract] [Full Text] [Related]
15. Oral contraceptives and relative risk of death from venous and pulmonary thromboembolism in the United States.
Seigel DG; Markush RE
Am J Epidemiol; 1969 Jul; 90(1):11-6. PubMed ID: 5794004
[No Abstract] [Full Text] [Related]
16. Oral contraceptives and thromboembolic disease.
Vessey MP
Am Heart J; 1969 Feb; 77(2):153-7. PubMed ID: 4883908
[No Abstract] [Full Text] [Related]
17. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
Herzog C
Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1321-9. PubMed ID: 394143
[No Abstract] [Full Text] [Related]
18. Hormonal steroid contraceptives: a further review of adverse reactions.
McQueen EG
Drugs; 1978 Oct; 16(4):322-57. PubMed ID: 359313
[No Abstract] [Full Text] [Related]
19. Contraceptives, thromboembolism and lipid metabolism.
de Gennes JL; Turpin G; Truffert J
Acta Endocrinol Suppl (Copenh); 1973; 173():182-3. PubMed ID: 4542099
[No Abstract] [Full Text] [Related]
20. Evaluation of rare adverse effects of systemic contraceptives.
Doll R; Vessey MP
Br Med Bull; 1970 Jan; 26(1):33-8. PubMed ID: 4904684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
